Daclizumab Biosimilar - Research Grade [ICH5021]
Catalogue Number: ICH5021-ICB
| Manufacturer: | IchorBio |
| Type: | Recombinant Monoclonal |
| Alias: | Alpha subunit IL-2R, interleukin 2 receptor |
| Shipping Condition: | Blue Ice |
| Unit(s): | 10 mg, 20 mg, 5 mg, 50 mg, 1 mg, 100 mg |
| Host name: | |
| Clone: | |
| Isotype: | IgG1 |
| Immunogen: | |
| Application: | FA |
Description
Description: RUO daclizumab biosimilar is a therapeutic humanized monoclonal antibody which was used for the treatment of adults with relapsing forms of multiple sclerosis. Daclizumab works by binding to CD25, the alpha subunit of the IL-2 receptor of T-cells.
Additional Text
Gene Name
IL2RA
Gene ID
3559
Concentration
5 mg/ml
Uniprot ID
P01589
Purification
Protein A/G Purified
Antibody Clonality
Recombinant Monoclonal
Application Notes
This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Storage Note
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
ICH5021 Datasheet
SUPPORT
outstanding technical support
PRODUCT
we offer a full product guarantee
DELIVERY
we offer free delivery to UK universities and non profit organisations